Breast cancer and pregnancy: diagnosis and treatment options

E. A. Velde, G. Sonke, E. Rutgers
{"title":"Breast cancer and pregnancy: diagnosis and treatment options","authors":"E. A. Velde, G. Sonke, E. Rutgers","doi":"10.1017/S1470903109990198","DOIUrl":null,"url":null,"abstract":"A 36-year-old woman had noticed a lump in her right breast, just after she had discovered she had been pregnant for about 6 weeks. At referral to our clinic, on physical examination a palpable mass was found in the upper quadrant of her right breast, sized 2 cm in diameter. Diagnostic mammography and ultrasound were performed elsewhere and showed an uncertain density on mammography and an uncertain hypoechoic structure on ultrasound cranial to the righter mammilla, sized 15 mm in diameter. Utrasound of the axilla showed no suspected lymph nodes. A core biopsy proved an adenocarcinoma. After discussing the different options, the patient preferred a skin-sparing mastectomy with nipple banking and sentinel node biopsy. The sentinel node was retrieved by 85 MBq technetium-99m nanocolloid intra-tumoural injection, without using blue dye. At histopathology the tumour was T1 (15 mm) in size, B&R grade II; the sentinel node was tumournegative after multiple slicing and IHC staining with Cam 5.2; oestrogen receptor was 100% positive and progestin receptor was 100% positive; HER2neu was negative. The margins were free. The Mammaprint showed a low-risk signature, that is no distant metastases within at least 5 years. Since the patient was in her first trimester of pregnancy, and the child was very much desired, finally, the patient opted for endocrine therapy. She will receive tamoxifen and ovarian suppression by LHRH agonist after her child delivery. She decided not to have adjuvant chemotherapy, particularly considering the high hormone responsiveness of the tumour and the Mammaprint low risk. In addition, due to her young age, she was referred to the genetic counselling department.","PeriodicalId":89901,"journal":{"name":"Breast cancer online : BCO","volume":"12 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2009-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1017/S1470903109990198","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Breast cancer online : BCO","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1017/S1470903109990198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4

Abstract

A 36-year-old woman had noticed a lump in her right breast, just after she had discovered she had been pregnant for about 6 weeks. At referral to our clinic, on physical examination a palpable mass was found in the upper quadrant of her right breast, sized 2 cm in diameter. Diagnostic mammography and ultrasound were performed elsewhere and showed an uncertain density on mammography and an uncertain hypoechoic structure on ultrasound cranial to the righter mammilla, sized 15 mm in diameter. Utrasound of the axilla showed no suspected lymph nodes. A core biopsy proved an adenocarcinoma. After discussing the different options, the patient preferred a skin-sparing mastectomy with nipple banking and sentinel node biopsy. The sentinel node was retrieved by 85 MBq technetium-99m nanocolloid intra-tumoural injection, without using blue dye. At histopathology the tumour was T1 (15 mm) in size, B&R grade II; the sentinel node was tumournegative after multiple slicing and IHC staining with Cam 5.2; oestrogen receptor was 100% positive and progestin receptor was 100% positive; HER2neu was negative. The margins were free. The Mammaprint showed a low-risk signature, that is no distant metastases within at least 5 years. Since the patient was in her first trimester of pregnancy, and the child was very much desired, finally, the patient opted for endocrine therapy. She will receive tamoxifen and ovarian suppression by LHRH agonist after her child delivery. She decided not to have adjuvant chemotherapy, particularly considering the high hormone responsiveness of the tumour and the Mammaprint low risk. In addition, due to her young age, she was referred to the genetic counselling department.
乳腺癌和妊娠:诊断和治疗方案
一名36岁的妇女发现自己的右乳房有一个肿块,就在她发现自己怀孕约6周后。在转介到我们诊所时,体格检查发现在她的右乳房上象限有一个可触及的肿块,直径为2厘米。在其他地方进行诊断性乳房x光检查和超声检查,乳房x光检查显示密度不确定,超声检查显示颅右乳不确定低回声结构,直径为15mm。腋窝超声未见可疑淋巴结。核心活检证实为腺癌。在讨论了不同的选择后,患者选择了保留皮肤的乳房切除术,乳头保留和前哨淋巴结活检。前哨淋巴结采用85 MBq锝-99m纳米胶体瘤内注射,不使用蓝色染料。组织病理学检查,肿瘤大小为T1 (15mm), B&R II级;前哨淋巴结经多次切片和Cam 5.2免疫组化染色后呈肿瘤阴性;雌激素受体100%阳性,黄体酮受体100%阳性;HER2neu为阴性。保证金是免费的。Mammaprint显示低风险特征,即至少5年内没有远处转移。由于患者处于怀孕的前三个月,并且非常想要孩子,最后,患者选择了内分泌治疗。她将在分娩后接受他莫昔芬和LHRH激动剂抑制卵巢。她决定不进行辅助化疗,特别是考虑到肿瘤对激素的高反应性和mamaprint的低风险。此外,由于她的年龄太小,她被转介到遗传咨询部门。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书